huan lu Xu

Dr. huan lu Xu

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2026 in Gastrointestinal Disorders
Verified
Journal Article
Open access
PDF file
JCJianlong Chen
Jianlong Chen
HXhuan lu Xu
huan lu Xu
YFYiwen Feng
Yiwen Feng
HSHong-Zhang Shen
Hong-Zhang Shen
Chronic atrophic gastritis (CAG) is a key precursor in the Correa cascade leading to gastric cancer and is driven by long-standing Helicobacter pylori infection, autoimmune reactions, environmental exposures, and persistent inflammation. Emerging evidence indicates that mild to moderate atrophy and part of intestinal metaplasia exhibit a degree of reversibility when etiological eradication, microenvironmental optimization, and regenerative stimulation are achieved. This review summarizes recent advances in the pathological basis, evaluation systems, therapeutic mechanisms, and clinical management strategies of CAG. Reversibility is closely related to residual glandular reserve, stem-cell plasticity, and effective mitigation of chronic inflammation. Current assessment tools integrate OLGA/OLGIM histological staging, high-quality endoscopy with AI assistance, and serological biomarkers. Fundamental interventions include early H. pylori eradication, mucosal protective agents, micronutrients, and small-molecule drugs targeting inflammation, oxidative stress, and epithelial regeneration. Novel strategies such as mesenchymal stem cells, exosomes, and focal endoscopic therapies demonstrate regenerative potential in preclinical studies. Traditional Chinese medicine provides multi-target regulation of inflammation, apoptosis, microecology, and stem-cell-related pathways, contributing to histological improvement. Contemporary guidelines emphasize early eradication, risk-stratified surveillance, and comprehensive intervention. Future directions focus on unified evaluation criteria, long-term prospective studies, multimodal combination regimens, and integration of AI-based risk modeling to achieve precise, cancer-preventive CAG management.

5 January 2026 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
XCXuanhua Chen
Xuanhua Chen
HXhuan lu Xu
huan lu Xu
SCshenghui chen
shenghui chen
WGWeigang Gu
Weigang Gu
ZWZhi-Jie Wang
Zhi-Jie Wang
XZXiaofeng Zhang
Xiaofeng Zhang
Cite this article as: Chen X, Xu H, Chen S, Gu W, Wang Z, Zhang X. A straw shows which way the wind blows: A successful cannulation of abnormal duodenal papilla. Turk J Gastroenterol. Published online January 5, 2026. doi 10.5152/tjg.2026.25493.

2 October 2026 in Gastrointestinal Disorders
Verified
Journal Article
Open access
PDF file
HXhuan lu Xu
huan lu Xu
RHRong Hu
Rong Hu
KJKe Jiang
Ke Jiang
XZXiaofeng Zhang
Xiaofeng Zhang
Background: Although non-ampullary duodenal epithelial tumors (NADETs) were historically considered rare, their detection has increased with high-resolution and image-enhanced endoscopy. Endoscopic resection is the preferred organ-preserving treatment for lesions without evidence of nodal metastatic risk, but the thin, vascular duodenal wall and exposure to bile and pancreatic juice create a narrow safety margin. Methods: This structured narrative review searched PubMed/MEDLINE, Embase, Web of Science Core Collection, and the Cochrane Library through 4 August 2026 and synthesized current guidance and clinical evidence. Results: Pooled conventional endoscopic mucosal resection (CEMR) data showed 93% successful removal and 15% recurrence, whereas contemporary endoscopic submucosal dissection (ESD) data showed 98.1% en bloc resection with 8.5% intraprocedural perforation. Cold snare resection is best supported for diminutive nonmalignant lesions; CEMR or underwater EMR is appropriate for most snareable lesions ≤ 20 mm; and hot EMR remains suitable for many larger lesions without invasive features. ESD should be reserved for lesions requiring en bloc histology in expert centers; nonlifting, fibrotic, large, or closure-challenging lesions may require endoscopic full-thickness resection, laparoscopic-endoscopic cooperative surgery, or surgery. Suspected deep invasion or nodal disease requires multidisciplinary evaluation. Conclusions: Treatment should be individualized according to lesion size, morphology, invasion depth, papillary relation-ship, closure feasibility, patient fitness, and local expertise. Suspected deep invasion or nodal disease requires multidisciplinary evaluation. Complete defect closure is central to safety, and sporadic and familial adenomatous polyposis-associated disease require separate assessment.